Edwards Wildman Palmer LLP
Macrocyclic hepatitis C serine protease inhibitors
The present invention relates to novel macrocyclic compounds and methods of treating a hepatitis C infection in a subject in need of such therapy with said macrocyclic compounds. The present invention further relates to pharmaceutical compositions comprising the compounds of the present invention, or pharmaceutically acceptable salts, esters, or prodrugs thereof, in combination with a pharmaceutically acceptable carrier or excipient.
Abbott Laboratories Enanta Pharmaceuticals, Inc.
A A A A C C A
A61P A61P A61P A61P C07D C07K A61P
inventional inventional inventional inventional inventional inventional inventional
Dale J. Jason P. Hui-Ju David J. Keith F. Yiyin
Kempf Shanley Chen Grampovnik McDaniel Ku